Rubella, also known as German measles or three day measles, is a contagious viral infection. Before a rubella vaccine became available in 1969, outbreaks of the disease occurred every 6 - 9 years. Now rubella is rare in locations where vaccination is standard practice. In the United States, the measles-mumps-rubella vaccine, given to children twice before they reach school age, has led to the eradication of the disease. However, it is important for parents to make sure their children are vaccinated. If a pregnant woman contracts rubella, the virus can cause serious birth defects or even be fatal to the fetus.
Rubella is caused by a virus. It can be spread in airborne droplets, such as from a cough or sneeze, from an infected person. Individuals can be contagious for as long as 1 week before a rash appears and up to 1 week after it disappears. Infants with congenital rubella syndrome (see Special Considerations section) may spread rubella virus in respiratory secretions and urine for up to 2 years.
These factors increase the risk for rubella:
Symptoms are usually mild. In up to half of all cases, the disease is so mild that symptoms are hard to identify. The most distinctive sign of rubella is swollen lymph nodes behind the ear, in the neck, and at the back of the head. A pink rash is usually the first sign in younger children. In older children and adults, it is more common to have a low-grade fever, malaise (feeling unwell), loss of appetite, swollen glands, and upper respiratory infection for 1 - 5 days before the onset of full blown disease.
Other signs and symptoms include:
Your health care provider will perform an exam to look for common signs and symptoms, and may perform blood tests or culture a sample of fluid from the nose or throat to check for the rubella virus.
The rubella vaccine causes immunity in 90 - 99% of those who receive it. Children should receive 2 doses [usually as part of the combination measles-mumps-rubella (MMR) vaccine] at least 4 weeks apart. Anyone born in or after 1957 should have at least one dose of MMR. Persons born before 1957 are considered immune. Women of childbearing age should still be vaccinated prior to becoming pregnant, or take a lab test to see if they are immune to the virus, even if they were born before 1957. (Having had rubella makes a person immune for life.)
In the past, some news reports have raised concerns about whether the MMR vaccine was linked to autism. However, a population based study investigating a potential association between the incidence of autism and the introduction of the MMR vaccine in the United States and Britain found no link between the two, and reports from the Centers for Disease Control and Prevention and the American Academy of Pediatrics have found the vaccine to be safe. It is more likely that, since autism is usually diagnosed between the ages of 18 months and 3 years -- the same time children receive the MMR vaccine -- timing caused questions about whether the events were related.
Rubella vaccine should not be given to anyone who:
There is no specific therapy to fight the rubella virus. Treatment is supportive, and the infection generally resolves on its own. Complications are rare. Individual symptoms, such as fever, arthritis, and joint pain, may be treated.
The MMR vaccine is the only effective prevention against rubella. No CAM method offers any immunity, but some alternative therapies may help alleviate symptoms of rubella. Anyone suspected of having contracted rubella should be seen immediately by a conventional medical practitioner.
No clinical trials have investigated the use of specific foods or nutrients to treat rubella. However, the following nutrients may be used to support the immune system in general. Check with your doctor to determine the proper dose for a child, and do not treat your child without medical supervision.
Following these nutritional tips may help reduce risks and symptoms:
You may address nutritional deficiencies with the following supplements:
Herbs are generally available as standardized, dried extracts (pills, capsules, or tablets), teas, or tinctures/liquid extracts (alcohol extraction, unless otherwise noted). Mix liquid extracts with favorite beverage. Dose for teas is 1 - 2 heaping teaspoonfuls/cup water steeped for 10 - 15 minutes (roots need longer).
Few studies have examined the effectiveness of specific homeopathic remedies. Professional homeopaths, however, may recommend one or more of the following treatments for rubella based on their knowledge and clinical experience. Before prescribing a remedy, homeopaths take into account a person's constitutional type -- your physical, emotional, and intellectual makeup. An experienced homeopath assesses all of these factors when determining the most appropriate remedy for a particular individual.
Electroacupuncture (in which acupuncture points are stimulated with electrodes) successfully treated two cases of visual and hearing impairments linked to congenital rubella syndrome (see Special Considerations section). Acupuncture may also help relieve joint pain.
Therapeutic massage may help relieve joint pain.
Most people who have rubella recover completely without permanent side effects and are immune to rubella afterward. This is not the case for a fetus infected in the womb. Fetal infection can cause serious long term effects (see Special Considerations section).
Complications are more common in adults than children and may include:
If a fetus is infected with rubella in the womb, this can cause severe defects known as congenital rubella syndrome. The younger the fetus is at the time of infection, the more likely the syndrome is to occur and the more severe the effects are likely to be. Temporary effects of congenital rubella syndrome may include:
Permanent effects of congenital rubella syndrome may include:
Abernathy E, Cabezas C, Sun H, Zheng Q, Chen MH, Castillo-Solorzano C, Ortiz AC, Osores F, Oliveira L, Whittembury A, Andrus JK, Helfand RF, Icenogle J. Confirmation of rubella within 4 days of rash onset: comparison of rubella virus RNA detection in oral fluid with immunoglobulin M detection in serum or oral fluid. J Clin Microbiol. 2009;47(1):182-8.
Afzal MA, Minor PD, Schild GC. Clinical safety issues of measles, mumps and rubella vaccines. Bull World Hlth Org. 2000;78(2):199-204.
Bhat KPL, Kosmeder JW 2nd, Pezzuto JM. Biological effects of resveratrol. Antioxid Redox Signal. 2001;3(6):1041-64.
Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea -- a review. J Am Coll Nutr. 2006;25(2):79-99.
Eo SK, Kim YS, Lee CK, Han SS. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J Ethnopharmacol. 1999;68(1-3):129-36.
Galewski R. Electroacupuncture: an effective treatment of some visual disorders. Acupuncture in Medicine. 1999;17(1):42-49.
Halperin SA, Ferrera G, Scheifele D, Predy G, Stella G, Cuccia M, Douha M, Willems P. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years. Vaccine. 2009;27(20):2701-6.
Hurwitz E, Morgenstern H. Effects of diphtheria-tetanus-pertussis or tetanus vaccination on allergies and allergy-related respiratory symptoms among children and adolescents in the United States. J Manipulative Physiol Ther. 2000;23:81-90.
Jones A, Cork C, Chowdhury U. Autistic spectrum disorders 2: diagnosis and management. Community Pract. 2006 Apr;79(4):128-30. Review.
LeBaron CW, Forghani B, Matter L, Reef SE, Beck C, Bi D, Cossen C, Sullivan BJ. Persistence of rubella antibodies after 2 doses of measles-mumps-rubella vaccine. J Infect Dis. 2009;200(6):888-99.
Maldonado Y. Rubella. In: Behrman RE, ed. Nelson Textbook of Pediatrics. Philadelphia, Penn: W.B. Saunders; 2000:951-953.
Mandell: Mandell, Douglass, and Bennett's Principles and Practice of Infectious Diseases, 7th ed. Philadelphia, PA. Elsevier Inc. 2009.
Ouhilal S. Viral diseases in pregnancy: a review of rubella, chickenpox, measles, mumps and 5th disease. Prim Care Update Ob/Gyn. 2000;7:31-34.
Peter G. Immunization practices. In: Behrman RE, ed. Nelson Textbook of Pediatrics. Philadelphia, Penn: W.B. Saunders; 2000:1081-1089.
Reef S, et al. Rubella. Chapter 11 in VPD Surveillance Manual. Atlanta, Ga: Centers for Disease Control and Prevention; 1999:1-11.
Rotsein OD. Oxidants and antioxidant therapy. Crit Care Clin. 2001;17(1):239-47.
Shi J, Yu J, Pohorly JE, Kakuda Y. Polyphenolics in grape seeds-biochemistry and functionality. J MedFood. 2003;6(4):291-9.
Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21(6):495-505.
Starr M. A rash of exanthems: how they affect children and pregnant women. Aus Fam Phys. 2000;29(7):631-637.
Taylor B, Miller E, Farrington CP, et al. Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet. 1999;353:2026-2029.
West R, Roberts PM. Measles, mumps and rubella vaccine: current safety issues. BioDrugs. 1999;12(6):423-429.
Williams JE. Review of antiviral and immunomodulating properties of plants of the Peruvian rainforest with a particular emphasis on Una de Gato and Sangre de Grado. Altern Med Rev. 2001;6(6):567-79.
Yoon JH, Baek SJ. Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med J. 2005;46(5):585-96.
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885